498 related articles for article (PubMed ID: 25665755)
1. The inhibition of Cdk5 activity after hypoxia/ischemia injury reduces infarct size and promotes functional recovery in neonatal rats.
Tan X; Chen Y; Li J; Li X; Miao Z; Xin N; Zhu J; Ge W; Feng Y; Xu X
Neuroscience; 2015 Apr; 290():552-60. PubMed ID: 25665755
[TBL] [Abstract][Full Text] [Related]
2. A 24-residue peptide (p5), derived from p35, the Cdk5 neuronal activator, specifically inhibits Cdk5-p25 hyperactivity and tau hyperphosphorylation.
Zheng YL; Amin ND; Hu YF; Rudrabhatla P; Shukla V; Kanungo J; Kesavapany S; Grant P; Albers W; Pant HC
J Biol Chem; 2010 Oct; 285(44):34202-12. PubMed ID: 20720012
[TBL] [Abstract][Full Text] [Related]
3. Activation of Cdk5/p25 and tau phosphorylation following chronic brain hypoperfusion in rats involves microRNA-195 down-regulation.
Sun LH; Ban T; Liu CD; Chen QX; Wang X; Yan ML; Hu XL; Su XL; Bao YN; Sun LL; Zhao LJ; Pei SC; Jiang XM; Zong DK; Ai J
J Neurochem; 2015 Sep; 134(6):1139-51. PubMed ID: 26118667
[TBL] [Abstract][Full Text] [Related]
4. Vitexin reduces hypoxia-ischemia neonatal brain injury by the inhibition of HIF-1alpha in a rat pup model.
Min JW; Hu JJ; He M; Sanchez RM; Huang WX; Liu YQ; Bsoul NB; Han S; Yin J; Liu WH; He XH; Peng BW
Neuropharmacology; 2015 Dec; 99():38-50. PubMed ID: 26187393
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the Inhibitory Elements in the p5 Peptide Fragment of the CDK5 Activator, p35, CDKR1 Protein.
Binukumar BK; Shukla V; Amin ND; Bhaskar M; Skuntz S; Steiner J; Winkler D; Pelech SL; Pant HC
J Alzheimers Dis; 2015; 48(4):1009-17. PubMed ID: 26444778
[TBL] [Abstract][Full Text] [Related]
6. TRPM7 inhibitor carvacrol protects brain from neonatal hypoxic-ischemic injury.
Chen W; Xu B; Xiao A; Liu L; Fang X; Liu R; Turlova E; Barszczyk A; Zhong X; Sun CL; Britto LR; Feng ZP; Sun HS
Mol Brain; 2015 Feb; 8():11. PubMed ID: 25761704
[TBL] [Abstract][Full Text] [Related]
7. Crosstalk between cdk5 and MEK-ERK signalling upon opioid receptor stimulation leads to upregulation of activator p25 and MEK1 inhibition in rat brain.
Ramos-Miguel A; García-Sevilla JA
Neuroscience; 2012 Jul; 215():17-30. PubMed ID: 22537847
[TBL] [Abstract][Full Text] [Related]
8. Profiling of p5, a 24 Amino Acid Inhibitory Peptide Derived from the CDK5 Activator, p35 CDKR1 Against 70 Protein Kinases.
Binukumar BK; Pelech SL; Sutter C; Shukla V; Amin ND; Grant P; Bhaskar M; Skuntz S; Steiner J; Pant HC
J Alzheimers Dis; 2016 Sep; 54(2):525-33. PubMed ID: 27567857
[TBL] [Abstract][Full Text] [Related]
9. Processing of cdk5 activator p35 to its truncated form (p25) by calpain in acutely injured neuronal cells.
Nath R; Davis M; Probert AW; Kupina NC; Ren X; Schielke GP; Wang KK
Biochem Biophys Res Commun; 2000 Jul; 274(1):16-21. PubMed ID: 10903889
[TBL] [Abstract][Full Text] [Related]
10. The levels of cdk5 and p35 proteins and tau phosphorylation are reduced during neuronal apoptosis.
Kerokoski P; Suuronen T; Salminen A; Soininen H; Pirttilä T
Biochem Biophys Res Commun; 2001 Feb; 280(4):998-1002. PubMed ID: 11162625
[TBL] [Abstract][Full Text] [Related]
11. Involvement of aberrant cyclin-dependent kinase 5/p25 activity in experimental traumatic brain injury.
Yousuf MA; Tan C; Torres-Altoro MI; Lu FM; Plautz E; Zhang S; Takahashi M; Hernandez A; Kernie SG; Plattner F; Bibb JA
J Neurochem; 2016 Jul; 138(2):317-27. PubMed ID: 26998748
[TBL] [Abstract][Full Text] [Related]
12. GSK-3β inhibitor TDZD-8 reduces neonatal hypoxic-ischemic brain injury in mice.
Huang S; Wang H; Turlova E; Abussaud A; Ji X; Britto LR; Miller SP; Martinez A; Sun HS; Feng ZP
CNS Neurosci Ther; 2017 May; 23(5):405-415. PubMed ID: 28256059
[TBL] [Abstract][Full Text] [Related]
13. The role of CDK5/P25 formation/inhibition in neurodegeneration.
Camins A; Verdaguer E; Folch J; Canudas AM; Pallàs M
Drug News Perspect; 2006 Oct; 19(8):453-60. PubMed ID: 17160145
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the JNK/AP-1 pathway reduces neuronal death and improves behavioral outcome after neonatal hypoxic-ischemic brain injury.
Nijboer CH; van der Kooij MA; van Bel F; Ohl F; Heijnen CJ; Kavelaars A
Brain Behav Immun; 2010 Jul; 24(5):812-21. PubMed ID: 19766183
[TBL] [Abstract][Full Text] [Related]
15. The regulation of cyclin-dependent kinase 5 activity through the metabolism of p35 or p39 Cdk5 activator.
Hisanaga S; Saito T
Neurosignals; 2003; 12(4-5):221-9. PubMed ID: 14673209
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of calpain-regulated p35/cdk5 plays a central role in sildenafil-induced protection against chemical hypoxia produced by malonate.
Barros-Miñones L; Martín-de-Saavedra D; Perez-Alvarez S; Orejana L; Suquía V; Goñi-Allo B; Hervias I; López MG; Jordan J; Aguirre N; Puerta E
Biochim Biophys Acta; 2013 Jun; 1832(6):705-17. PubMed ID: 23415811
[TBL] [Abstract][Full Text] [Related]
17. Peptides derived from Cdk5 activator p35, specifically inhibit deregulated activity of Cdk5.
Kesavapany S; Zheng YL; Amin N; Pant HC
Biotechnol J; 2007 Aug; 2(8):978-87. PubMed ID: 17526058
[TBL] [Abstract][Full Text] [Related]
18. TFP5 peptide, derived from CDK5-activating cofactor p35, provides neuroprotection in early-stage of adult ischemic stroke.
Ji YB; Zhuang PP; Ji Z; Wu YM; Gu Y; Gao XY; Pan SY; Hu YF
Sci Rep; 2017 Jan; 7():40013. PubMed ID: 28045138
[TBL] [Abstract][Full Text] [Related]
19. Dexamethasone-induced neuroprotection in hypoxic-ischemic brain injury in newborn rats is partly mediated via Akt activation.
Feng Y; Lu S; Wang J; Kumar P; Zhang L; Bhatt AJ
Brain Res; 2014 Nov; 1589():68-77. PubMed ID: 25304361
[TBL] [Abstract][Full Text] [Related]
20. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration.
Patrick GN; Zukerberg L; Nikolic M; de la Monte S; Dikkes P; Tsai LH
Nature; 1999 Dec; 402(6762):615-22. PubMed ID: 10604467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
